What next as Moderna finds support at $130?
Moderna Inc. (NASDAQ:MRNA) has been strong since it rolled out COVID-19 vaccines. The demand for vaccines has started to slow down. The current year’s sales are projected to decline. Investors need to know what to expect from a company that is perfectly rated for value, growth, and momentum. COVID-19 vaccine is the most successful of
The post What next as Moderna finds support at $130? appeared first on Invezz.